Loading...
Guest User
Welcome! Please login.
* - Tentative Dates
The company intends to utilize the Net Proceeds from the Issue towards the following objects:
Solara Active Pharma Sciences Ltd's revenue increased by 13.82% and profit after tax (PAT) rose by 61.85% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 28.99 | 29.45 | 26.14 |
| Revenue | 14.66 | 12.88 | 16.46 |
| Profit After Tax | -0.22 | -0.58 | 2.21 |
| Amount in ₹ Crore | |||
Solara Active Pharma Sciences Limited was founded in February 2017. The company is a global, research and development-focused, pure-play API company engaged in the manufacture and development of APIs, providing contract manufacturing and development services to global companies. The company has a highly compliant manufacturing base spanning six major multi-product facilities and is supported by a team of more than 2500 employees. The company operates in 75 countries, with extensive operations in the key markets of North America, Europe, Japan, South Korea, the Middle East and North Africa. The company is able to create strategic value in the B2B sector with a basket of high-quality products, a compliant manufacturing base, long-term supply security and strong customer support.
The innovative and entrepreneurial spirit drives the combination of technology, science and innovation to create value-oriented products that meet customers' needs.
The driving force is to improve the well-being of patients worldwide, and concrete steps are taken to promote innovation in the field of active ingredients to ensure high-quality healthcare.
